MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines Post published:October 30, 2020 Post category:Press Release
Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing Post published:October 16, 2020 Post category:Press Release
MindMed Announces $25 Million Bought Deal Public Offering Post published:October 9, 2020 Post category:Press Release
MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines Post published:October 5, 2020 Post category:Press Release
MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin Post published:September 24, 2020 Post category:Press Release
MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD Post published:August 25, 2020 Post category:Press Release
Can Taking MDMA with LSD Help Prevent a ‘Bad Trip’? New Clinical Trial Investigates Post published:August 19, 2020 Post category:Clinical Trials/News
Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results Post published:August 14, 2020 Post category:Press Release